Baillie Gifford - HOMOLOGY MEDICINES INC ownership

HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 57 filers reported holding HOMOLOGY MEDICINES INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of HOMOLOGY MEDICINES INC
ValueSharesWeighting
Q2 2022$1,0000.0%4810.0%0.00%
Q1 2022$1,000
-50.0%
4810.0%0.00%
Q4 2021$2,000
-50.0%
4810.0%0.00%
Q3 2021$4,000
+33.3%
4810.0%0.00%
Q2 2021$3,000
-40.0%
4810.0%0.00%
Q1 2021$5,0000.0%4810.0%0.00%
Q4 2020$5,0004810.00%
Other shareholders
HOMOLOGY MEDICINES INC shareholders Q3 2023
NameSharesValueWeighting ↓
5AM Venture Management, LLC 4,535,919$5,307,0251.53%
Western Standard LLC 250,060$292,5700.26%
OUP Management Co., LLC 64,000$74,8800.17%
Vivo Capital, LLC 370,068$432,9800.05%
Temasek Holdings (Private) Ltd 5,650,996$6,611,6650.04%
GEORGE KAISER FAMILY FOUNDATION 39,320$46,0040.01%
American Investment Services, Inc. 36,955$43,2380.01%
RBF Capital, LLC 58,700$68,6790.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 185,100$216,5670.01%
XTX Topco Ltd 21,188$24,7900.00%
View complete list of HOMOLOGY MEDICINES INC shareholders